...
首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
【24h】

p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.

机译:L3环锌结合域,DNA倍性和S期分数中的p53突变是结直肠癌的独立预后指标:一项为期5年的随访研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

p53 gene alterations are among the most common events observed in colorectal cancer,and are accompanied frequently by DNA aneuploidy and high proliferative activity. The prognostic significance of such mutations remains controversial. We prospectively evaluated the prognostic significance of p53 mutations, DNA-ploidy, and S phase fraction (SPF) in a consecutive series of 160 colorectal cancer patients (median follow-up 71 months). Tumor DNA was screened for p53 mutations by PCR/single-strand conformational polymorphism/sequencing. DNA-ploidy and SPF were assessed by DNA flow cytometry. p53 mutations were detected in 68 of 160 (42.5%) cases. In 56% (38 of 68) of these, p53 mutations were found in conserved areas of the gene and in 44% (30 of 68 cases) outside the conserved regions. Eighteen of the 68 cases (26%) had mutations in the L3 loop, 11 of 68 (16%) in the L1 loop-sheet-alpha helix motif, and 39 of 68 (58%) outside L3 and loop-sheet-alpha helix. Seventy-five percent of the cases (120 of 160) showed DNA aneuploidy, whereas 18% of these (22 of 120) were multiclonal. The major independent predictors for both disease relapse and death were advanced Dukes' stage, p53 mutations affecting L3 loop, DNA-aneuploid tumors, and high SPF (>18.5%). Our results show that mutations in L3 functional domain, more than any mutations, are important biological indicators to predict the outcome of patients indicating that these mutations have biological relevance in terms of colorectal cancer disease course.
机译:p53基因改变是在大肠癌中最常见的事件之一,并经常伴有DNA非整倍性和高增殖活性。此类突变的预后意义仍然存在争议。我们前瞻性评估了p53突变,DNA倍性和S期分数(SPF)在连续160例大肠癌患者中的预后意义(中位随访71个月)。通过PCR /单链构象多态性/测序筛选肿瘤DNA的p53突变。通过DNA流式细胞术评估DNA倍性和SPF。在160例病例中有68例(42.5%)检测到p53突变。在其中的56%(68个中的38个)中,在该基因的保守区域发现了p53突变,在保守区之外的44%(68个案例中的30个)中发现了p53突变。 68例患者中有18例(26%)在L3环中发生突变,L1环-α-螺旋结构中有11例(68%),L3和环-α-α以外的68例中有39例(58%)螺旋。 75%的病例(160个病例中的120个)表现出DNA非整倍性,而其中18%(120个病例中的22个)是多克隆的。疾病复发和死亡的主要独立预测因素是Dukes晚期,影响L3环的p53突变,DNA非整倍体肿瘤和高SPF(> 18.5%)。我们的结果表明,L3功能域中的突变比任何突变更重要,是预测患者预后的重要生物学指标,表明这些突变与大肠癌疾病进程具有生物学相关性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号